STAAR Surgical Company
US ˙ NasdaqGM ˙ US8523123052

SecuritySTAA / STAAR Surgical Company
InstitutionElkfork Partners LLC
Latest Disclosed Ownership120,758 shares
Latest Disclosed Value $ 3,113,000
Elkfork Partners LLC reports 3.06% decrease in ownership of STAA / STAAR Surgical Company

On November 14, 2019 - Elkfork Partners LLC filed a 13F-HR form disclosing ownership of 120,758 shares of STAAR Surgical Company (US:STAA) valued at $3,113,141 USD as of September 30, 2019. The entity filed a previous 13F-HR on August 13, 2019 disclosing 124,564 shares of STAAR Surgical Company. This represents a change in shares of -3.06% during the quarter. The current value of the position is $3,621,532 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2019-11-14 2019-09-30 13F STAAR Surgical COM 852312305 120,758 -3,806 -3.06 3,113 -14.95 0.0757
2019-08-13 2019-06-30 13F STAAR Surgical COM 852312305 124,564 46,552 59.67 3,660 37.23 0.0894
2019-05-13 2019-03-31 13F STAAR Surgical COM 852312305 78,012 -616 -0.78 2,667 6.30 0.0669
2019-02-13 2018-12-31 13F STAAR Surgical COM 852312305 78,628 -528 -0.67 2,509 -33.97 0.0708
2018-11-14 2018-09-30 13F STAAR Surgical COM 852312305 79,156 13,090 19.81 3,800 85.55 0.0903
2018-08-13 2018-06-30 13F STAAR Surgical COM 852312305 66,066 1,782 2.77 2,048 115.35 0.0527
2018-05-10 2018-03-31 13F STAAR Surgical COM 852312305 64,284 0 0.00 951 -4.52 0.0256
2018-02-24 2017-12-31 13F/A-1 STAAR Surgical COM 852312305 64,284 11,528 21.85 996 51.60 0.0270
2018-02-22 2017-12-31 13F STAAR Surgical COM 852312305 46,752 -6,004 725
2017-11-14 2017-09-30 13F STAAR Surgical COM 852312305 52,756 -5,654 -9.68 657 4.12 0.0191
2017-08-14 2017-06-30 13F STAAR Surgical COM 852312305 58,410 -16,962 -22.50 631 -14.61 0.0190
2017-05-03 2017-03-31 13F STAAR Surgical COM 852312305 75,372 0 0.00 739 -9.66 0.0227
2017-02-10 2016-12-31 13F STAAR Surgical COM 852312305 75,372 75,372 818 0.0269
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.